JUNO
Juno Lighting, Inc.
Set alert
- Open
- 86.96
- Prev close
- 86.96
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 2.68M
- EPS
- -4.16
- P/E
- -20.89
- Div yield
- 0.00%
More statistics
- Low
- 86.96
- High
- 86.96
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 7, 2018
- 50-d avg
- 0.00
- 200-d avg
- 0.00
News
11 months ago prnewswire.com
Seren Juno and Ribbon Achieve 20Tbps Transmission on 10,000 km JUNO Trans-Pacific Cable
PLANO, Texas , Nov. 12, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the…
2 years ago businesswire.com
NTT DATA-led JUNO Submarine Cable Plans to Deploy Ciena's WaveLogic 6 to Boost Network Capacity
TOKYO--(BUSINESS WIRE)--Seren Juno Network Co., Ltd. and Seren Juno Network America Inc (Seren), operator of the NTT DATA-led JUNO submarine cable system, will deploy Ciena's (NYSE: CIEN) GeoMesh…
2 years ago https://www.marketscreener.com
Britain's Royal Mint launches coin for 80th anniversary of D-Day landings
LONDON (Reuters) - Britain's Royal Mint has launched a coin marking next month's 80th anniversary of the 1944 D-Day landings, when 150,000 Allied soldiers invaded France to drive out the forces of…
9 years ago businesswire.com
Juno Therapeutics to Report Third Quarter 2017 Financial Results on Wednesday, November 1
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial…
9 years ago businesswire.com
Juno Therapeutics to Report Second Quarter 2017 Financial Results on Thursday, August 3
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the second quarter 2017 on Thursday, August 3, 2017, after the close of U.S.-based financial…
9 years ago businesswire.com
Juno Therapeutics to Report First Quarter 2017 Financial Results on Thursday, May 4
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the first quarter 2017 on Thursday, May 4, 2017, after the close of U.S.-based financial markets.…
9 years ago businesswire.com
Juno Therapeutics to Report Full Year and Fourth Quarter 2016 Financial Results on Wednesday, March 1
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the close…
9 years ago businesswire.com
Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical Hold
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced…
9 years ago businesswire.com
Juno Therapeutics to Report Third Quarter 2016 Financial Results on Wednesday, November 9
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the third quarter 2016 on Wednesday, November 9, 2016, after the close of U.S.-based financial…
10 years ago businesswire.com
Juno Therapeutics to Report Second Quarter 2016 Financial Results on Thursday, August 4
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the second quarter 2016 on Thursday, August 4, 2016, after the close of U.S.-based financial…
10 years ago businesswire.com
Juno Therapeutics Reports Clinical Hold on the JCAR015 Phase II ROCKET Trial
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced…
-
10 years ago benzinga.com
12 Stocks Moving In Wednesday's Pre-Market Session
12 Stocks Moving In Wednesday's Pre-Market Session
10 years ago businesswire.com
Juno Therapeutics to Report First Quarter 2016 Financial Results on Monday, May 9
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the first quarter 2016 on Monday, May 9, 2016, after the close of U.S.-based financial markets.…
10 years ago businesswire.com
Juno Therapeutics to Report Full Year and Fourth Quarter 2015 Financial Results on Monday, February 29
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the fourth quarter and year ended December 31, 2015 on Monday, February 29, 2016, after the close…
10 years ago businesswire.com
Juno Therapeutics to Report Third Quarter 2015 Financial Results on Tuesday, November 10
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the third quarter of 2015 on Tuesday, November 10, 2015, after the close of U.S.-based financial…
-
11 years ago benzinga.com
Dyax, Juno Therapeutics Soar Following Biotech Index Rebalance
Dyax, Juno Therapeutics Soar Following Biotech Index Rebalance